Growth Metrics

10x Genomics (TXG) Long-Term Debt Repayments (2020)

10x Genomics recorded quarterly Long-Term Debt Repayments of $31.3 million in Q1 2020.

10x Genomics' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $31.3 million for Q1 2020.

  • In Q1 2020, Long-Term Debt Repayments changed N/A year-over-year to $31.3 million; the TTM figure through Dec 2020 stood at $31.3 million (changed N/A YoY), while the FY2020 annual figure was $31.3 million, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at $31.3 million for Q1 2020 at 10x Genomics.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $31.3 million in Q1 2020 to a low of $31.3 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 12.35 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 15.00 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 23.55 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 31.26 Mn
Mar 31, 2020 31.26 Mn